Directors & Officers

As of January 1, 2024

OutsideOutside Director

IndependentIndependent officer pursuant to Article 436-2 of the regulations of Tokyo Stock Exchange, Inc.

Directors

Photo:Dr. Osamu Okuda Dr. Osamu OkudaRepresentative Director, President & CEO
Supervisory responsibility for Corporate Planning, ASPIRE Transformation, Business Transformation, Partnering, External Affairs and Audit
In charge of Partnering Dept., External Affairs Dept., and Audit Dept.

Date of Birth    April 5, 1963

  • 1987 Joined the Company
  • 2008 Department Manager of Lifecycle Management Dept. II
  • 2009 Department Manager and Lifecycle Leader of Lifecycle Management Dept. II
  • 2011 President of Roche Products (Ireland) Limited
  • 2013 Head of Oncology Unit, Marketing & Sales Div. of the Company
  • 2014 Executive Officer, Head of Oncology Unit,
    Marketing & Sales Div. of the Company
  • 2015 Executive Officer, Head of Corporate Planning Dept. of the Company
  • 2017 Executive Vice President, Head of Corporate Planning Dept. of the Company
  • 2018 Executive Vice President, Co-Head of Project & Lifecycle Management Unit
  • 2020 Representative Director and President (to present)
    COO
  • 2021 CEO (to present)
Photo:Dr. Hisafumi Yamada Dr. Hisafumi YamadaDirector, Executive Vice President
Supervisory responsibility for Project & Lifecycle Management (R&D), Research, Translational Research, Clinical Development, Pharmaceutical Technology and Manufacturing Technology

Date of Birth    July 12, 1957

  • 1991 Joined Nippon Roche K.K.
  • 2002 Department Manager of Pharmaceutical Research Dept. IV
  • 2007 Director, Forerunner Pharma Research Co., Ltd.
  • 2009 Vice President and General Manager of Research Div.
    Head, C&C Research Laboratories (Korea)
  • 2012 Director and COO, Chugai Pharmabody Research Pte. Ltd. (Singapore)
  • 2016 Senior Vice President and General Manager of Research Div.
  • 2018 Executive Vice President and Head of Translational Research Div.
  • 2018 Executive Vice President (to present)
  • 2022 Director (to present)
Photo:Toshiaki Itagaki Toshiaki ItagakiDirector, Executive Vice President & CFO
Supervisory responsibility for Finance & Accounting, Corporate Communication and Procurement

Date of Birth    November 23, 1960.

  • 1983 Joined the Company
  • 2007 General Manager of Finance & Accounting Dept.
  • 2010 Department Manager of Planning & Research Dept.
  • 2012 Department Manager of Marketing & Sales Planning Dept.
  • 2015 Vice President, General Manager of Finance & Accounting Dept.
  • 2018 Executive Vice President & CFO (to present)
    Head of Finance Supervisory Div.
    Head of IT Supervisory Div. and Head of Finance & Accounting Dept.
  • 2022 Director (to present)
Photo:Dr. Mariko Momoi OutsideIndependent Dr. Mariko Y Momoi Professor Emeritus of Jichi Medical University
Visiting Professor of School of Medicine, Shinshu University
Regent of Tokyo Medical University (part-time)

Date of Birth    February 24, 1948

  • 1994 Head of Department of Pediatrics, Jichi Medical University
  • 2006 Director of Jichi Children’s Medical Center Tochigi
  • 2010 Dean of School of Medicine, Jichi Medical University
  • 2012 Visiting Professor of School of Medicine, Shinshu University (to present)
  • 2013 Professor Emeritus of Jichi Medical University (to present)
    Vice President of International University of Health and Welfare
  • 2014 Director of Japanese Medical Specialty Board (part-time)
  • 2015 Vice President of International University of Health and Welfare and Head of IUHW Hospital
  • 2017 Chief Medical Officer of Ryoumou Seishi Ryogoen, Kiryu Ryoiku Futabakai Social Welfare Corporation
  • 2018 Regent of Tokyo Medical University (part-time) (to present)
  • 2020 Director of the Company (to present)
Photo:Dr. Fumio Tateishi OutsideIndependent Dr. Fumio Tateishi Honorary Advisor of OMRON Corporation

Date of Birth    July 6, 1949

  • 1975 Joined Tateisi Electronics Co. (currently OMRON Corporation)
  • 1997 Director of OMRON Corporation (“OMRON”)
  • 1999 Managing Executive Officer of OMRON
  • 2001 Senior General Manager, Corporate Strategic Planning HQ of OMRON
  • 2003 Executive Officer and Executive Vice President of OMRON
    President, Industrial Automation Business Company of OMRON
  • 2008 Director and Executive Vice Chairman of OMRON
  • 2013 Chairman of the Board of OMRON
  • 2023 Director of the Company (to present)
    Honorary advisor of OMRON Corporation
Photo:Hideo Teramoto OutsideIndependent Hideo Teramoto President of Dai-ichi Life Research Institute, Inc.
Outside Director of Imperial Hotel, Ltd.

Date of Birth    May 20,1960

  • 1983 Joined The Dai-ichi Mutual Life Insurance Company
  • 2012 Director, Managing Executive Officer, Deputy Chief General Manager of Group Management Headquarters, and General Manager of Corporate Planning Department of The Dai-ichi Life Insurance Company, Limited. (“DLI”)
  • 2013 Director, Managing Executive Officer, and Deputy Chief General Manager of Group Management Headquarters of DLI
  • 2015 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of DLI
  • 2016 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of Dai-ichi Life Holdings, Inc. (“DLH”)
    Director and Senior Managing Executive Officer of DLI
  • 2017 Director of DLH
    Representative Director and Vice Chairman of DLI
  • 2020 Director, Vice Chairman, and General Manager of Innovation Strategy Unit of DLH
  • 2021 Representative Director, Vice Chairman, and Executive Officer of DLH
  • 2022 Director of DLH
    President of Dai-ichi Life Research Institute, Inc. (to present)
  • 2023 Director of the Company (to present)
    Outside Director of Imperial Hotel, Ltd. (to present)
Photo:Dr. Christoph Franz Dr. Christoph Franz Vice-Chairman of the Board of Directors of Zurich Insurance Group Ltd. (Switzerland)
Member of the Board of Directors of Stadler Rail Ltd. (Switzerland)

Date of Birth    May 2, 1960

  • 1990 Joined Deutsche Lufthansa AG
  • 1994 Member of the Executive Board and CEO of Passenger Transport Division of Deutsche Bahn AG
  • 2004 CEO of Swiss International Air Lines AG
  • 2009 Deputy Chairman of the Executive Board of Deutsche Lufthansa AG
  • 2011 Chairman of the Executive Board and CEO of Deutsche Lufthansa AG
  • 2014 Chairman of the Board of Directors of Roche Holding Ltd.
  • 2017 Director of the Company (to present)
Photo:Dr. James H. Sabry Dr. James H. Sabry Global Head of Roche Pharma Partnering and Member of the Roche
Enlarged Corporate Executive Committee

Date of Birth    December 19, 1958

  • 1997 Co-founder, President and CEO of Cytokinetics
  • 2008 President and CEO of Arete Therapeutics
  • 2010 Global Head and Vice President of Genentech Partnering
  • 2013 Global Head and Senior Vice President of Genentech Partnering
  • 2018 Global Head of Roche Pharma Partnering and Member of the Roche Enlarged Corporate Executive Committee (to present)
  • 2019 Director of the Company (to present)
Photo:Teresa A. Graham Teresa A. Graham CEO of Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee

Date of Birth    December 30, 1973

  • 2005 Joined Genentech, Inc. as Product Manager
  • 2010 Sales Manager of Genentech
  • 2011 Marketing Director, Rituxan Immunology of Genentech
  • 2012 Marketing Director, ACTEMRA of Genentech
  • 2013 Senior Director, Field Reimbursement Management of Genentech
  • 2015 Lifecycle Leader, ACTEMRA of Roche
  • 2017 Vice President, Rheumatology / Nephrology of Genentech
  • 2018 Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lung & GI Oncology Sales of Genentech
  • 2019 Head, Global Product Strategy of Roche Pharmaceuticals
  • 2023 CEO of Roche Pharma, F. Hoffmann-La Roche Ltd.
    Director of the Company (to present)

Audit & Supervisory Board Members

Photo:Dr. Yoshiaki Ohashi Dr. Yoshiaki Ohashi Audit & Supervisory Board Member (full-time)

Date of Birth    January 8, 1960

  • 1988 Joined the Company
  • 2004 Department Manager, Quality & Regulatory Compliance Dept.
  • 2009 Department Manager, Drug Safety Coordination Dept.
  • 2011 Global PV Head, Pharmacovigilance Manager
  • 2013 Head of Drug Safety Div. and Department Manager of Drug Safety Coordination Dept.
  • 2015 Vice President, Head of Drug Safety Div.
    Vice President, Head of Quality & Regulatory Compliance Unit, and Head of Drug Safety Div.
  • 2018 Senior Vice President, Head of Quality & Regulatory Compliance Unit and Head of Drug Safety Div.
  • 2021 Senior Vice President
    Audit & Supervisory Board Member (to present)
Photo:Shigehiro Yamada Dr. Shigehiro Yamada Audit & Supervisory Board Member (full-time)

Date of Birth    August 5, 1964

  • 2005 Joined the Company
  • 2016 Department Manager of PT Planning Dept.
  • 2018 Department Manager of Corporate Planning Dept. of Chugai Pharma Manufacturing Co., Ltd.
  • 2019 Head of Corporate Social Responsibility Dept.
    Head of Sustainability Dept.
  • 2023 Executive Director of Human Resources Management Dept.
    Audit & Supervisory Board Member (to present)
Photo:Takaaki Nimura OutsideIndependent Takaaki NimuraRepresentative of Nimura Certified Public Accountant Office

Date of Birth    October 25, 1949

  • 1974 Joined Arthur Young & Co., Tokyo Office
  • 1980 Seconded to Asahi & Co., Osaka Office
  • 1983 Seconded to Arthur Young & Co., Los Angeles Office
  • 1989 Partner, Asahi Shinwa & Co.
  • 1993 Joined Showa Ota & Co.
  • 1997 Senior Partner, Showa Ota & Co.
  • 2008 Executive Board Member, Ernst & Young ShinNihon LLC
  • 2010 Established Nimura Certified Public Accountant Office
  • 2012 Outside Director, Sony Corporation
  • 2016 Outside Audit & Supervisory Board Member of the Company (to present)
Photo:Kenichi Masuda OutsideIndependent Kenichi Masuda Partner of Anderson Mōri & Tomotsune
Outside Director of Bridgestone Corporation
Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd.

Date of Birth    January 11, 1963

  • 1988 Registered as an attorney-at-law (Daini Tokyo Bar Association)
    Joined Anderson Mōri & Tomotsune
  • 1993 Registered as an attorney-at-law in the state of New York
  • 1997 Partner of Anderson Mōri & Tomotsune (to present)
  • 2007 Outside Corporate Auditor of LIFENET INSURANCE COMPANY
  • 2010 Part-time Lecturer at School of Law, The University of Tokyo
  • 2011 Outside Corporate Auditor of Bridgestone Corporation
  • 2016 Outside Director of Bridgestone Corporation (to present)
    Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd. (formerly Mercuria Investment Co., Ltd.) (to present)
  • 2019 Visiting Professor of School of Law, The University of Tokyo
  • 2020 Outside Audit & Supervisory Board Member of the Company (to present)
Photo:Yumiko Waseda OutsideIndependent Yumiko Waseda Partner Attorney-at-Law/Partner Patent Attorney, Tokyo Roppongi Law and Patent Office
Outside Audit & Supervisory Board Member of IHI Corporation

Date of Birth    January 29, 1960

  • 1985 Joined Matsuda Masayuki Law & Patent Office (currently Mori Hamada & Matsumoto)
  • 2004 Vice President of Daini Tokyo Bar Association
  • 2005 Executive Governor of Japan Federation of Bar Associations
  • 2013 Joined Tokyo Roppongi Law & Patent Office
  • 2014 Outside Audit & Supervisory Board Member of Kao Corporation
  • 2015 Outside Audit & Supervisory Board Member of Asahi Group Holdings, Ltd.
  • 2016 President of Daini Tokyo Bar Association
    Vice President of Japan Federation of Bar Associations
  • 2021 Outside Audit & Supervisory Board Member of IHI Corporation (to present)
  • 2023 Outside Audit & Supervisory Board Member of the Company (to present)

Executive Officers

Tetsuya Yamaguchi
Executive Vice President
Supervisory responsibility for Project & Lifecycle Management (Marketing), Drug Safety, Medical Affairs, Foundation Medicine and Special Mission for CVF
Head of Foundation Medicine Unit
Junichi Ebihara
Executive Vice President
Supervisory responsibility for Legal, Intellectual Property
In charge of Legal Dept., Intellectual Property Dept.
Shinji Hidaka
Executive Vice President
Supervisory responsibility for Marketing & Sales
Yoshiyuki Yano
Executive Vice President
Supervisory responsibility for Human Resource Management and ESG
In charge of Human Resources Management Dept. and ESG Dept.
Satoko Shisai
Executive Vice President
Supervisory responsibility for Digital Transformation
Head of Digital Transformation Unit
Iwaaki Taniguchi
Senior Vice President
Head of Finance Supervisory Div. and Head of Finance & Accounting Dept.
Tsukasa Kusano
Vice President
Head of Project & Lifecycle Management Unit
Dr. Kaori Ouchi
Vice President
Supervisory responsibility for Risk Management, Compliance and Quality & Regulatory Compliance
Shinya Takuma
Vice President
Head of Manufacturing Technology Div.
Dr. Hitoshi Iikura
Vice President
Head of Translational Research Div.
Masayoshi Higuchi
Vice President
Head of Quality & Regulatory Compliance Unit, Head of Business Strategy & Compliance Dept.
In charge of Risk & Compliance Dept.
Norihisa Onozawa
Vice President
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept. and Business Transformation Dept.
  • Like
  • Post
  • LINE it!
  • E-mail

Company Outline

Back to top